Search

everythinglearnresearchcommunity

for

Search:↓

Using CRISPR for gene editing in the body is promising but needs better delivery methods to be more efficient and specific.

RNA delivery is best for in-body use, while RNP delivery is good for outside-body use. Both methods are expected to greatly impact future treatments.

Niosomes are a promising, stable, and cost-effective drug delivery system with potential for improved targeting and safety.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

Gene therapy shows promise for healing chronic wounds but needs more research to overcome challenges.

Gene therapy shows promise for improving wound healing, but more research is needed for human use.

Improving artificial vascular grafts requires better materials and surface designs to reduce blood clotting and support blood vessel cell growth.

Ultrasound can help deliver genes to cells to stimulate tissue regeneration and enhance hair growth, but more research is needed to perfect the method.

Effective delivery of gene editors is crucial for safe and successful gene editing in healthcare and agriculture.

The gelatin/β-TCP scaffold with nanoparticles improves wound healing and skin regeneration.

Efficient delivery systems are needed for the clinical use of CRISPR-Cas9 gene editing.

ELIP-based CRISPR delivery improves heart disease gene editing but needs more testing.

Ultrasound-assisted gene therapy could revolutionize tissue regeneration by improving gene delivery.

Genetically-altered adult stem cells can help in wound healing and are becoming crucial in regenerative medicine and drug design.

Non-viral delivery systems and stimuli-responsive nanoformulations can improve CRISPR-Cas9 gene therapy.

Biomaterials can improve non-viral gene delivery by enhancing DNA uptake and reducing toxicity.

Liposomal carriers can improve tissue regeneration by stabilizing and retaining growth factors.

Gene therapy shows promise for treating skin disorders and cancer, but faces technical challenges.

Hair follicles could be used for targeted drug delivery, with liposomal systems showing promise for this method.

Hair follicles could be used to deliver drugs effectively, with the right understanding and methods.

Cutaneous gene therapy could become a viable treatment for skin and hair disorders with improved vector development and gene expression control.

MicroRNAs and AI can improve cashmere goat hair quality and aid in hair disorder diagnosis.

Advancements in nanoformulations for CRISPR-Cas9 genome editing can respond to specific triggers for controlled gene editing, showing promise in treating incurable diseases, but challenges like precision and system design complexity still need to be addressed.

Researchers developed a method to label and study human hair follicle stem cells using a fluorescent protein.

Applying a special DNA plasmid to the skin can make it thicker and stronger.

Scientists have created a new hair loss treatment using ultrasound to deliver gene-editing particles, which resulted in up to 90% hair regrowth in mice.

Non-viral vectors show promise for safe and effective CRISPR/Cas9 gene editing in treating diseases.

Intranasal delivery of gene therapy shows promise for treating ischemic stroke.

Topical treatments can deliver active molecules to skin stem cells, potentially helping treat skin and hair disorders, including skin cancers and hair loss.

Using polyethylenimine-DNA to deliver the hTERT gene can stimulate hair growth and may be useful in treating hair loss, but there could be potential cancer risks.